TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ +0.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GERN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-358.8%
+19.1% +44.6% -6.2% -22.4% +1,215.3% +20.5% -16.3% +10.9% +19.0% +18.2% -1.4%
+9.7% -1.8% -1.2% -21.8% -4.5% +13.4% +17.2% -1.0% +141.9% +61.8% -99.7%
+15.6% +2.9% -3.8% -17.1% -11.4% +4.7% +4.3% +19.1%
-202.6% -165.6% -98.0% +2,646.2% -52.2% +20.5% -1,229.1%
-31.3% -36.7% -71.9% +0.0% +2,481.3% -2.9% -48.4% +108.2% +92.6% -18.1% -92.8%
+11,902.7% +162.2% -438.3% -484.4% -13.7% -390.5% -41.2%
-97.4% -54.6% -5.0% +8,268.0% -79.0% -78.0% +450.4% -26.7%
+0.0% +0.0% +0.0% +4.3% -100.0% +16.4% -100.0%
-97.4% -54.6% -5.0% +8,268.0% -79.0% +763.4% -71.2% +79.7% +314.9% -7.6% -99.3%
-172.3% -263.4% -218.1% -11.9% -36.6% -30.1% -114.7%
-363.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?